196 related articles for article (PubMed ID: 37905107)
1. Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma.
Cheng X; An J; Lou J; Gu Q; Ding W; Droby G; Wang Y; Wang C; Gao Y; Shelton A; Satterlee AB; Mann BE; Hsiao YC; Liu CW; Liu K; Hingtgen S; Wang J; Liu Z; Miller R; Wu D; Vaziri C; Yang Y
bioRxiv; 2023 Oct; ():. PubMed ID: 37905107
[TBL] [Abstract][Full Text] [Related]
2. Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma.
Cheng X; An J; Lou J; Gu Q; Ding W; Droby G; Wang Y; Wang C; Gao Y; Shelton A; Satterlee AB; Mann BE; Hsiao YC; Liu CW; Liu K; Hingtgen S; Wang J; Liu Z; Miller R; Wu D; Vaziri C; Yang Y
Res Sq; 2023 Oct; ():. PubMed ID: 37886584
[TBL] [Abstract][Full Text] [Related]
3. Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma.
Cheng X; An J; Lou J; Gu Q; Ding W; Droby GN; Wang Y; Wang C; Gao Y; Anand JR; Shelton A; Satterlee AB; Mann B; Hsiao YC; Liu CW; Lu K; Hingtgen S; Wang J; Liu Z; Miller CR; Wu D; Vaziri C; Yang Y
Nat Commun; 2024 Mar; 15(1):1957. PubMed ID: 38438348
[TBL] [Abstract][Full Text] [Related]
4. Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair.
Higuchi F; Nagashima H; Ning J; Koerner MVA; Wakimoto H; Cahill DP
Clin Cancer Res; 2020 Apr; 26(7):1690-1699. PubMed ID: 31900275
[TBL] [Abstract][Full Text] [Related]
5. Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression.
Hanisch D; Krumm A; Diehl T; Stork CM; Dejung M; Butter F; Kim E; Brenner W; Fritz G; Hofmann TG; Roos WP
Cell Death Dis; 2022 Apr; 13(4):293. PubMed ID: 35365623
[TBL] [Abstract][Full Text] [Related]
6. The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2-HO-1 Axis.
Chuang HY; Hsu LY; Pan CM; Pikatan NW; Yadav VK; Fong IH; Chen CH; Yeh CT; Chiu SC
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638586
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a Novel Temozolomide Resistant Subline of Glioblastoma Multiforme Cells and Comparative Transcriptome Analysis With Parental Cells.
Ha HA; Yang JS; Tsai FJ; Li CW; Cheng YD; Li J; Hour MJ; Chiu YJ
Anticancer Res; 2021 May; 41(5):2333-2347. PubMed ID: 33952458
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide-resistant Glioblastoma Depends on HDAC6 Activity Through Regulation of DNA Mismatch Repair.
Kim GW; Lee DH; Yeon SK; Jeon YH; Yoo J; Lee SW; Kwon SH
Anticancer Res; 2019 Dec; 39(12):6731-6741. PubMed ID: 31810938
[TBL] [Abstract][Full Text] [Related]
9. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
[TBL] [Abstract][Full Text] [Related]
10. Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells.
Cui B; Johnson SP; Bullock N; Ali-Osman F; Bigner DD; Friedman HS
J Biomed Res; 2010 Nov; 24(6):424-35. PubMed ID: 23554659
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O
Jin L; Kiang KM; Cheng SY; Leung GK
Lab Invest; 2022 Feb; 102(2):194-203. PubMed ID: 34625658
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of MSH6 is associated with temozolomide resistance in human glioblastoma.
Sun Q; Pei C; Li Q; Dong T; Dong Y; Xing W; Zhou P; Gong Y; Zhen Z; Gao Y; Xiao Y; Su J; Ren H
Biochem Biophys Res Commun; 2018 Feb; 496(4):1040-1046. PubMed ID: 29366782
[TBL] [Abstract][Full Text] [Related]
13. STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B.
Yuan S; Yan Q; Zhao ZY; Zhang JL; Zhang H; Yin H; Yuan Z
Cancer Cell Int; 2022 Aug; 22(1):248. PubMed ID: 35945579
[TBL] [Abstract][Full Text] [Related]
14. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair.
Goellner EM; Grimme B; Brown AR; Lin YC; Wang XH; Sugrue KF; Mitchell L; Trivedi RN; Tang JB; Sobol RW
Cancer Res; 2011 Mar; 71(6):2308-17. PubMed ID: 21406402
[TBL] [Abstract][Full Text] [Related]
15. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide.
Tentori L; Ricci-Vitiani L; Muzi A; Ciccarone F; Pelacchi F; Calabrese R; Runci D; Pallini R; Caiafa P; Graziani G
BMC Cancer; 2014 Mar; 14():151. PubMed ID: 24593254
[TBL] [Abstract][Full Text] [Related]
17. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells.
Li XD; Wang MJ; Zheng JL; Wu YH; Wang X; Jiang XB
Cancer Sci; 2021 Nov; 112(11):4543-4552. PubMed ID: 34390075
[TBL] [Abstract][Full Text] [Related]
19. Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
van Thuijl HF; Mazor T; Johnson BE; Fouse SD; Aihara K; Hong C; Malmström A; Hallbeck M; Heimans JJ; Kloezeman JJ; Stenmark-Askmalm M; Lamfers ML; Saito N; Aburatani H; Mukasa A; Berger MS; Söderkvist P; Taylor BS; Molinaro AM; Wesseling P; Reijneveld JC; Chang SM; Ylstra B; Costello JF
Acta Neuropathol; 2015 Apr; 129(4):597-607. PubMed ID: 25724300
[TBL] [Abstract][Full Text] [Related]
20. Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.
Stritzelberger J; Distel L; Buslei R; Fietkau R; Putz F
Clin Transl Oncol; 2018 Apr; 20(4):508-516. PubMed ID: 28825189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
